Given investment horizon of 30 days, Delcath Systems Inc. is expected to under-perform the Columbia. In addition to that, Delcath is 1.31 times more volatile than Columbia Laboratories Inc.. It trades about -0.17 of its total potential returns per unit of risk. Columbia Laboratories Inc. is currently generating about -0.07 per unit of volatility. If you would invest 68.00 in Columbia Laboratories Inc. on April 25, 2012 and sell it today you would lose (4.00) from holding Columbia Laboratories Inc. or give up 5.88% of portfolio value over 30 days.
Diversification
Very weak diversification
Overlapping area represents amount of risk that can be diversified away by holding Delcath Systems Inc. and Columbia Laboratories Inc. in the same portfolio (assuming nothing else is changed)